DAFTAR PUSTAKA

1. Sheehan S, Montgomery A, Carey M, McAuliffe F, Eogan M, Gleeson R, et

al. Oxytocin Bous Versus Oxytocin Bolus and Infusion for Control of Blood

Loss at Elective Caesarean Section: Double Blind, Placebo Controlled,

Randomised Trial. Biomedical Journal. 2011; 343: 1-11.

2. Department of Anesthesiology. Obstetric Anesthesia Guidelines. 2009th ed.

New Orleans: Tulane University; 2009. hlm. 23-4

3. American Society of Anesthesiologists Task Force on Obstetric Anesthesia.

Practice Guidelines for Osbtetric Anesthesia. Anesthesiology. 2007; 106(4):

843-63.

4. Kim J, Lee J, Kim E, Min M, Ban J, SG L. The Effect of Type of Anesthesia

on Intra- and Postoperative Blood Loss at Elective Cesarean Section. Korean

Journal of Anesthesiology. 2012; 62(2): 125-9.

5. Yegin A, Ertug Z, Yilmaz M, Erman M. The Effects of Epidural Anesthesia

and General Anesthesia on Newborns at Cesarean Section. Turkish Journal of

Medical Sciences. 2003; 33: 311-4.

6. American Society of Anesthesiologists Task Force on Obstetric Anesthesia;

The Society for Obstetric Anesthesia and Perinatology. Practice Guidelines for

Obstetric Anesthesia. Anesthesiology. 2016; 124(2): 1-31.

7. Havas F, Sungur M, Yenigun Y, Karadeniz M, Kilic M, Seyhan T. Spinal

Anesthesia for ELective Cesarean Section is Associated with Shorter Hospital

41
 42

Stay Compared to General Anesthesia. AGRI. 2013; 25(2): 55-63.

8. El Tahan M, Warda O, Rashad A, Yasseen A, Ramzy E, Ahmady M, et al.

Effects of Preoperative Sublingual Misoprostol on Uterine Tone during

Isofurane Anesthesia for Cesarean Section. Revista Brasileira de

Anestesiologia. 2012; 62(5): 625-35.

9. Walfish M, Neuman A, Wlody D. Maternal Haemorrhage. British Journal of

Anaesthesia. 2009; 103: i47-56.

10. Yuen P. Oxytotic Agents for the Management of Postpartum Haemorrhage.

The Hong Kong Medical Diary. 2011; 16(10): 26-7.

11. Bodur S, Gun I, Ozdamar O, Babayihit M. Safety of Uneventful Cesarean

Section in Terms of Hemorrhage. International Journal of Clinical and

Experimental Medicine. 2015; 8(11): 21653-8.

12. Anderson J, Etches D. Prevention and Management of Postpartum

Hemmorrhage. American Academy of Family Physicians. 2007; 75(6): 875-

82.

13. Boopathi A, Nayak S, Rao A, Rao B. Oxytocin Versus Methylerhometrine in

the Active Management of Third Stage of Labor. Open Journal of Obstetrics

and Gynecology. 2014; 4: 666-71.

14. Gohil J, Beenu T. A Study to Compare the Efficacy of Misoprostol, Oxytocin,

Methyl-ergometrine and Ergometrine-Oxytocin in Reducing Blood Loss in

Active Management of 3rd Stage of Labor. The Journal of Obstetrics and

Gynecology of India. 2011; 61(4): 408-12.

15. McDonald S, Abbott J, Higgins S. Prophylactic Ergometrine-Oxytocin Versus

Oxytocin for the Third Stage of Labor (Review). Chochrane Database of

Systematic Reviews. 2007; 4: 1-10.

16. Sumikura H, Inada E. Uterotonics and Tocolytics for Anesthesiologists.

Current Opinion of Anesthesiology. 2016; 29: 1-6.

17. Senturk S, Kagitci M, Balik G, Arslan H, Sahin F. The Effect of the

Combined Use of Methylergonovine and Oxytocin during Caesarean Section

in the Prevention of Post-partum Haemorrhage. Basic and Clinical

Pharmacology & Toxicology. 2015; 1-6.

18. Ramya K, Shivanna S, Gopal N. Intravenous Methergin Versus Intramuscular

Oxytocin in Active Management of Third Stage Labour. International Journal

of Recent Trends in Science and Technology. 2015; 14(2): 260-4.

19. Resvitas P, Redjeki I, Bisri T. Perbandingan antara Sevofluran dan Enfluran

terhadap Kontraksi Uterus, Jumlah Perdarahan, Skor APGAR pada Seksio

Sesarea Elektif. Jurnal Anestesi Perioperatif. 2015; 3(1): 57-64.

20. Datta S, Kodali B, Segal S. Anesthesia for Cesarean Delivery. Dalam Datta S,

Kodali B, Segal S, editors. Obstetric Anesthesia Handbook. New York:

Springer Science + Business Media, LLC; 2006. hlm. 201-16.

21. Caton D. Cesarean Delivery. Dalam Nathan N, editor. Chestnut's Obstetric

Anesthesia: Principles and Practice. China: Saunders, an imprint of Elsevier

Inc.; 2014. hlm. 569-77.

22. Tsen L. Anesthesia for Cesarean Delivery. Dalam Nathan N, editor. Chestnut's
 44

Obstetric Anesthesia: Principles and Practice. China: Saunders, an imprint of

Elsevier Inc.; 2014. hlm. 575-7.

23. Butterworth J, Mackey D, Wasnick J. Maternal & Fetal Physiology &

Anesthesia. In Butterworth J, Mackey D, Wasnick J, editors. Morgan &

Mikail's Clinical Anestheriology. USA: McGraw-Hill Education, LLC; 2013.

hlm. 836-59.

24. Burns P. Isoflurane & Sevoflurane: Mechanics & Effects. Clinician's Brief.

2014; 23-6.

25. Yeo S, Holdcroft A, Yentis S, Stewart A, Basset P. Analgesia with

Sevoflurane during Labour: II. Sevoflurane Compared With Entonox for

Labour Analgesia. British Journal of Anaesthesia. 2007; 98(1): 110-5.

26. Gilani S, Sofi K. Is Nitrous Oxide Necessary for General Anaesthesia? Journal

of Ayub Medical College. 2008; 20(4): 149-52.

27. Vejnovic T, Costa S, Ignatov A. New Technique for Caesarean Section.

Geburtshilfe Frauenheilkd. 2012; 72(9): 840-5.

28. Milonas I, Friese K. Indications for and Risks of Elective Cesarean Section.

Deutsches Arzteblatt International. 2015; 112: 489-95.

29. Martini F, Nath J. Fundamentals of Anatomy & Physiology United States of

America: Pearson Education, Inc; 2009.

30. Liu M, Belfore L, Shen Y, Scerbo M. Uterine Contraction Modeling and

Simulation. Paper. USA: Old Dominion University, Virginia Modeling,

Analysis, and Simulation Center; 2009.

31. Ara B, Nisa Z, Kakar P, Salam A, Aslam M. Atonic Uterus: Risk Factors and

Management as a Cause of Primary Postpartum Hemorrhage. The Professional

Medical Journal. 2014; 21(6): 1122-7.

32. Anggrainy V, Irianto , Irmayani. Faktor-faktor yang Mempengaruhi Kejadian

Atonia Uteri di RSUP NTB Tahun 2012. Media Bina Ilmiah. 2013; 7(5): 1-6.

33. Rulz M, Azevedo C, Ferreira M, Mamede M. Association between

Hypertensive Disorders and Postpartum Hemorrhage. Revista Gaucha de

Enfermagem. 2015; 36: 55-61.

34. Sarna M, AK S, Gomez M, Oriol N. Intravenous Oxytocin in Patient

Undergoing Elective Caesarean Section. Anesthesia & Analgesia. 1997; 84:

736-6.

35. Manrique M, Munar B, Frances G, Suescun L, Montferrer E, Fernandez L.

Update on the Use of Utetotonic Agents. Revista Espanola de Anestesiologia

y Reanimacion. 2012; 59(2): 91-7.

36. World Health Organization. WHO Recommendations for the Prevention and

Treatment of Postpartum Haemorrhage Italy: WHO Press; 2012.

37. Gallos I, Williams H, Price M, Merriel A, Gee H, Lissauer D, et al. Uterotonic

Agents for Preventing Postpartum Haemorrhage: a Network Meta-analysis.

Cochrane Database of Systematic Reviews. 2015; 5: 1-11.

38. Prescriber's Digital Reference. Methylergonovine Maleate-Drug Summary.

[Online].; 2017 [cited 2017 March 03. Available from: http://www.pdr.net.

39. Food and Drug Administration. Methergine. [Online].; 2012 [cited 2017
 46

March 02. Available from: http://www.accessdata.fda.gov.

40. Frolich M. Maternal & Fetal Physiology & Anesthesia. Dalam Butterworth J,

Mackey D, Wasnick J, editors. Morgan & Mikhail's Clinical Anesthesiology.

USA: McGraw-Hill Education, LLC; 2013. hlm. 835-6.

41. Royal College of Obstetricians and Gynaecologists. Postpartum haemorrhage:

ergometrine (query bank). [Online].; 2013 [cited 2016 Januari 13. Available

from: https://www.rcog.org.uk.